| 1 |
32597315 | Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease. | 2021 Sep |
1 |
| 2 |
33309661 | Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs. | 2021 Jan 31 |
1 |
| 3 |
34392751 | Molecular modelling on SARS-CoV-2 papain-like protease: an integrated study with homology modelling, molecular docking, and molecular dynamics simulations. | 2021 Sep |
1 |